As with other diseases and disorders, the likelihood of developing an addiction differs from person to person, and no single factor determines whether a person will become addicted to drugs. In general, the more risk factors a person has, the greater the chance that taking drugs will lead to drug use and addiction. Protective factors, on the other hand, reduce a person's risk. Risk and protective factors may be either environmental or biological.
Opioids: Methadone (Dolophine®, Methadose®), buprenorphine (Suboxone®, Subutex®, Probuphine® , Sublocade™), and naltrexone (Vivitrol®) are used to treat opioid addiction. Acting on the same targets in the brain as heroin and morphine, methadone and buprenorphine suppress withdrawal symptoms and relieve cravings. Naltrexone blocks the effects of opioids at their receptor sites in the brain and should be used only in patients who have already been detoxified. All medications help patients reduce drug seeking and related criminal behavior and help them become more open to behavioral treatments. A NIDA study found that once treatment is initiated, both a buprenorphine/naloxone combination and an extended release naltrexone formulation are similarly effective in treating opioid addiction. Because full detoxification is necessary for treatment with naloxone, initiating treatment among active users was difficult, but once detoxification was complete, both medications had similar effectiveness.
There are several ways to approach addiction, and every case is different. The best approach is usually one tailored to the specific needs of the individual with a clear goal in mind. Selecting the right drug treatment program begins with the first call or interaction. Intake coordinators at The Recovery Village ask a number of questions regarding the nature of the substance use disorder to find the best treatment program to meet the individual’s needs.
The methamphetamine binge is followed by a phase called “tweaking,” a state characterized by restlessness, anxiety, paranoia, agitation, sleeplessness, and intense cravings. “Tweakers” may experience delusional thinking, psychotic episodes, hallucinations, and violent impulses. Severe itching and the urge to harm oneself are common at this point. Methamphetamine withdrawal is complicated by the fact that many heavy users are malnourished, dehydrated, and sleep deprived. Meth-induced psychosis can continue for weeks or months after the addict stops using. In a case study published in the Journal of Clinical Psychiatry, one methamphetamine addict continued to have auditory hallucinations, fears of persecution, and paranoid delusions for a year after treatment.
Drug addiction is a disease of the body and brain. Also called substance use disorder, drug addiction triggers uncontrollable behaviors and renders a person unable to control their use of medication, alcohol, cigarettes, or drugs—whether they are legal or not. Addictive substances such as nicotine, alcohol, opioid medications, and marijuana are considered drugs just as much as heroin, cocaine, or methamphetamine. Once you are addicted to a substance, you will feel compelled to use it, regardless of the damage that use does to your body, your brain, and your life.
Alcohol is considered safe in moderation, but when occasional use becomes more common and begins to interfere with everyday life, it is typically classed as abuse. The UK Government’s guidelines on alcohol consumption states that no more than fourteen units of alcohol should be consumed by adult men and women each week; which means that consuming a large amount at one time (binge drinking), may still be considered abuse, without it being a regular occurrence.
Traditional alcohol treatment programs rely on evidence-based strategies such as psychotherapy, behavioral modification therapy, peer group counseling, nutritional counseling and 12-step programs. Rehabilitation begins with detox, a cleansing process that allows the patient to withdraw safely and comfortably from alcohol. After detox, the patient participates in a structured series of therapies that are designed to help him or her modify destructive behaviors and create a sober life.
All drugs–nicotine, cocaine, marijuana and others–affect the brain’s “reward” circuit, which is part of the limbic system. This area of the brain affects instinct and mood. Drugs target this system, which causes large amounts of dopamine—a brain chemical that helps regulate emotions and feelings of pleasure—to flood the brain. This flood of dopamine is what causes a “high.” It’s one of the main causes of drug addiction. Making the Decision to Get Help - Alcohol Rehab Review
As a dual diagnosis patient, you could expect to work with doctors and therapists who are experts in treating the conditions you suffer from. Your treatment may be very different from what others in your facility are receiving. Your stay at the residential facility might be longer as well. But rest assured that you will get the specialised treatment you need to deal with your dual diagnosis.
During alcoholism treatment, therapy teams provide lessons on relapse prevention. These lessons are designed to help people spot the people, places, and things that can drive them to return to drinking. With the help of these lessons, people can learn to both avoid and/or handle their triggers so they won’t pick up an alcoholic beverage when they’re under stress.
Upon exiting treatment, a patient may be prescribed a drug like disulfiram, which prevents the body from chemically processing alcohol, causing an unpleasant reaction if the patient relapses or attempts to relapse. Because of disulfiram’s toxicity, it has to be taken under the supervision of a doctor, as unregulated usage can cause strong, even fatal reactions.
Nalmefene, an opiate antagonist that is similar in its chemical structure to naltrexone, is one of the most recent drugs being investigated for the treatment of alcoholism. Like naltrexone (sold as ReVia, Depade, or Vivitrol), nalmefene deprives the person struggling with substance use of the pleasurable feelings associated with drinking. But nalmefene is less toxic to the liver than naltrexone. As of 2013, nalmefene was still undergoing clinical trials through the U.S. National Institutes of Health before receiving FDA approval. From Rehab to a Body Bag | Dying for Treatment: VICE Reports (Full Length)